Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Armata Pharmaceuticals, Inc (ARMP)  
$0.32 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 24,940,000
Market Cap: 7.93(M)
Last Volume: 4,742 Avg Vol: 4,729
52 Week Range: $0.3179 - $0.3179
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Co. is developing and advancing its primary clinical phage candidate for Pseudomonas aeruginosa. Co. is also developing a phage product candidate for Staphylococcus aureus for the treatment of S. aureus bacteremia. In addition, Co. has phage development efforts underway to target other indications including non-cystic fibrosis bronchiectasis, prosthetic joint infections and hospitalized pneumonia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 129
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Rychlik Richard Corporate Controller and PFO   •       –      –    2024-03-14 4 A $0.00 $0 D/D 10,000 10,000     -
   Birx Deborah Chief Executive Officer   •       •      –    2024-03-14 4 A $0.00 $0 D/D 60,000 260,000     -
   Birx Deborah Chief Executive Officer   •       •      –    2023-12-21 4 A $0.00 $0 D/D 200,000 200,000     -
   Innoviva Strategic Opportunities Llc Director   –       •       •   2022-03-31 4 B $5.00 $26,926,040 I/I 5,385,208 16,365,969 2.25     -
   Innoviva Strategic Opportunities Llc Director   –       •       •   2022-02-09 4 B $5.00 $18,073,960 I/I 3,614,792 10,980,761 2.25     -
   Innoviva Strategic Opportunities Llc Director   –       •       •   2021-03-17 4 B $3.25 $13,929,289 I/I 4,285,935 6,153,847 2.25     -
   Innoviva Strategic Opportunities Llc Director   –       •       •   2021-01-26 4 B $3.25 $6,070,714 I/I 1,867,912 1,867,912 2.25     -
   Theravance Inc 10% Owner   –       –       •   2020-03-27 4 B $2.87 $22,149,687 D/D 7,717,661 8,710,800 2.45     -
   Delta Dental Of Wisconsin, Inc. 10% Owner   –       –       •   2019-05-09 3 IO $0.00 $0 I/I 0 478,681     -
   Delta Dental Of Wisconsin, Inc. 10% Owner   –       –       •   2019-05-09 3 IO $0.00 $0 D/D 0 1,628,994     -
   Bastiani Richard Director   –       •      –    2019-05-09 3 IO $0.00 $0 D/D 0 13,889     -
   Morris Duane Alfred VP of OperationsOfficer   •       –      –    2019-05-09 3 IO $0.00 $0 D/D 0 26,144     -
   Varnum Brian President and CDOOfficer   •       –      –    2019-05-09 3 IO $0.00 $0 D/D 0 32,162     -
   Patrick Todd Chief Executive OfficerOfficer   •       •      –    2019-05-09 3 IO $0.00 $0 D/D 0 204,086     -
   Parker H Stewart Director   –       •      –    2019-05-09 3 IO $0.00 $0 D/D 0 13,889     -
   Perry Michael S Director   –       •      –    2018-03-22 4 B $1.10 $200,002 I/I 181,820 411,105 2.1     -
   Cook Jeremy Curnock Director   –       •      –    2018-03-22 4 B $1.10 $200,002 I/I 181,820 411,105 2.1     -
   Grint Paul C Chief Executive Officer   •       •      –    2017-12-08 4 A $0.62 $371 D/D 599 599     -
   Perry Michael S Director   –       •      –    2017-09-19 4 B $0.00 $0 I/I 105,015 229,285 2.02     -
   Cook Jeremy Curnock Director   –       •      –    2017-09-19 4 B $0.00 $0 I/I 105,015 229,285 2.02     -
   Perry Michael S Director   –       •      –    2017-06-29 4 B $0.00 $0 I/I 5,757 124,270 2.02     -
   Cook Jeremy Curnock Director   –       •      –    2017-06-29 4 B $0.00 $0 I/I 5,757 124,270 2.02     -
   Intrexon Corp 10% Owner   –       –       •   2016-12-29 4 S $0.45 $18,900 I/I (42,000) 674,169     -
   Intrexon Corp 10% Owner   –       –       •   2016-12-28 4 S $0.47 $39,771 I/I (84,620) 694,246     -
   Intrexon Corp 10% Owner   –       –       •   2016-12-27 4 S $0.51 $25,704 I/I (50,400) 734,696     -

  129 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed